Source: FinanzNachrichten

Cytovance: Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs

This collaboration offers an integrated solution for customers seeking to outsource the development and manufacturing of microbial and mammalian-expressed peptide drugs, with scalable options that...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
Ping Zhang's photo - CEO of Cytovance

CEO

Ping Zhang

CEO Approval Rating

82/100

Read more